Press Release
NPS Pharmaceuticals to Report Third Quarter 2008 Financial Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Oct. 31, 2008--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its third quarter 2008 financial results on Wednesday, November 5, 2008 before the market open. The announcement will be followed by a conference call and webcast at 8:00 am Eastern Time.
To participate in the conference call, dial (866) 700-5192 and use passcode 81185910. International callers may dial (617) 213-8833, using the same passcode. In addition, a live audio of the conference call will be available over the Internet. Interested parties can access the event through the NPS website, http://www.npsp.com.
A replay will be available at (888) 286-8010, with passcode 68666007, until midnight Eastern Time, November 19, 2008. International callers may access the replay by dialing (617) 801-6888, using the same passcode. The webcast will also be available through the NPS website for the same period.
About NPS Pharmaceuticals
NPS Pharmaceuticals is developing specialty therapeutics for gastrointestinal and endocrine disorders with high unmet medical needs. The company is currently advancing two late-stage programs. Teduglutide, a proprietary analog of GLP-2, is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome as GATTEX(TM) and in preclinical development for gastrointestinal mucositis and pediatric gastrointestinal conditions. NPSP558 (parathyroid hormone 1-84 (rDNA origin) injection) is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes strategic partnerships with Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.
CONTACT: NPS Pharmaceuticals, Inc.
Gail Brophy, 908-450-5335
SOURCE: NPS Pharmaceuticals, Inc.
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader’s sole risk.